Buscar
Mostrando ítems 1-10 de 182
Response predictors to treatment with pegylated interferon in chronic hepatitis B
(Brazilian Society of Infectious Diseases, 2010-10-01)
The clinical and epidemiological importance of chronic B hepatitis is currently unquestionable as a cause of end-stage liver disease and hepatocellular carcinoma. Recently, predictors of treatment response of this disease ...
Treatment of human papillomavirus with peg-interferon alfa-2b and ribavirin
(ContextoSalvadorBrasil, 2007)
Using pegylated interferon alfa-2b and ribavirin to treat chronic hepatitis patients infected with hepatitis C virus genotype 1: Are nonresponders and relapsers different populations?
(Contexto, 2007-12-01)
The combination of pegylated interferon (PEG-INF) and ribavirin is currently the best treatment for chronic hepatitis C, providing a sustained virological response (SVR) in 54%-63% of patients. In patients infected with ...
Using pegylated interferon alfa-2b and ribavirin to treat chronic hepatitis patients infected with hepatitis C virus genotype 1: Are nonresponders and relapsers different populations?
(Contexto, 2007-12-01)
The combination of pegylated interferon (PEG-INF) and ribavirin is currently the best treatment for chronic hepatitis C, providing a sustained virological response (SVR) in 54%-63% of patients. In patients infected with ...
Therapeutic approach to acute hepatitis C
(ContextoSalvadorBrasil, 2007)